Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: hybrid virus vaccines - CDC/NIAID/Takeda

Next Previous
Drug Profile

Research programme: hybrid virus vaccines - CDC/NIAID/Takeda

Alternative Names: Combination plague/smallpox vaccine - CDC/NIAID/Takeda; Plague (Y. pestis) vaccine - CDC/NIAID/Takeda; WNVax - CDC/NIAID/Takeda

Latest Information Update: 23 Jul 2014

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Centers for Disease Control and Prevention; InViragen LLC; National Institute of Allergy and Infectious Diseases
  • Developer Advanced BioScience Laboratories; Centers for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases; Takeda Pharmaceuticals USA
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Smallpox; West Nile virus infections; Yersinia infections

Most Recent Events

  • 23 Jul 2014 No development reported - Preclinical for Smallpox in USA (Injection)
  • 23 Jul 2014 No development reported - Preclinical for West Nile virus infections in USA (unspecified route)
  • 23 Jul 2014 No development reported - Preclinical for Yersinia infections in USA (unspecified route)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top